This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 51694216
Submitted by lobbyist on: November 4, 2019 11:09:26 AM
Accepted by Registrar on: November 4, 2019 11:22:59 AM
Lobbyist Information
| Retfalvi, Andrew |
| 595 Bay St., Suite 401 | |
|
Toronto, ON, M5G 2C2
|
416-886-1255 |
| Canada |
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbyist Firm Information
| Global Public Affairs |
| 595 Bay St., Suite 401 | |
|
Toronto, ON, M5G 2C2
|
416-597-3470 |
| Canada |
Client Information
| Knight Therapeutics Inc. |
| Knight is a specialty pharmaceutical company focused on innovative prescription pharmaceuticals, consumer health products and medical devices in Canada. |
| 3400 de Maisonneuve W. Suite 1055 | |
|
Montreal, QC, H3Z 3B8
|
514-484-4483 |
| Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
| November 4, 2019 | |
| December 31, 2019 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Mental Health and Addictions
Arranging meeting between an individual and a public office holder
Arranging and attending a meeting regarding treatments for opioid use disorder under the Ministry of Health's BC Pharmacare program.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | November 4, 2019 |